BMC Chemistry (May 2024)

Discovery of novel cholesteryl ester transfer protein (CETP) inhibitors by a multi-stage virtual screening

  • Yanfeng Liu,
  • Liangying Deng,
  • Feng Ding,
  • Qiang Wang,
  • Shuran Zhang,
  • Nana Mi,
  • Wenhui Zhang,
  • Bailin Zeng,
  • Huangjin Tong,
  • Lixing Wu

DOI
https://doi.org/10.1186/s13065-024-01192-5
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Cholesteryl ester transfer protein (CETP) is a promising therapeutic target for cardiovascular diseases. It effectively lowers the low-density lipoprotein cholesterol levels and increases the high-density lipoprotein cholesterol levels in the human plasma. This study identified novel and highly potent CETP inhibitors using virtual screening techniques. Molecular docking and molecular dynamics (MD) simulations revealed the binding patterns of these inhibitors, with the top 50 compounds selected according to their predicted binding affinity. Protein–ligand interaction analyses were performed, leading to the selection of 26 compounds for further evaluation. A CETP inhibition assay confirmed the inhibitory activities of the selected compounds. The results of the MD simulations revealed the structural stability of the protein–ligand complexes, with the binding site remaining significantly unchanged, indicating that the five compounds (AK-968/40709303, AG-690/11820117, AO-081/41378586, AK-968/12713193, and AN-465/14952302) identified have the potential as active CETP inhibitors and are promising leads for drug development. Graphical Abstract

Keywords